Katherine Stueland, CHIEF EXECUTIVE OFFICER at GeneDx Holdings Corp. (WGS), sold 3,692 shares at $84.22 ($311K) on 2026-09-09, disclosed to the SEC on 2026-09-11.
Seasonal sale ($311k) by CHIEF EXECUTIVE OFFICER — this insider has traded WGS in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| WGS | SELL | 2026-06-11 | $196K | — | Filing → |
| WGS | SELL | 2026-05-01 | $142K | — | Filing → |
| WGS | SELL | 2026-03-30 | $5.9M | — | Filing → |